دورية أكاديمية

Design of Olanzapine/Lutrol Solid Dispersions of Improved Stability and Performances.

التفاصيل البيبلوغرافية
العنوان: Design of Olanzapine/Lutrol Solid Dispersions of Improved Stability and Performances.
المؤلفون: Cavallari, Cristina, Fini, Adamo, Ceschel, Giancarlo
المصدر: Pharmaceutics; Dec2013, Vol. 5 Issue 4, p570-590, 21p
مصطلحات موضوعية: OLANZAPINE, CRYSTALLIZATION, POLYMERS, MICELLES, DIFFERENTIAL scanning calorimetry, METASTABLE states
مستخلص: Eleven solid dispersions containing olanzapine, with carriers of different composition (Lutrol® F68, Lutrol® F127, Gelucire® 44/14), were prepared and examined by thermal (differential scanning calorimetry (DSC); thermomicroscopy (HSM)) and X-ray diffraction (XRD) analysis, both as fresh or aged (one year) samples. Drug and carriers were preliminarily selected in order to avoid problems related to the aging of the formulation, according to the solubility parameters of carriers and drug. These parameters make it possible to predict the low solubility of olanzapine in the carriers (alone or in mixtures). Systems containing only Lutrol (also in the presence of Transcutol®) contain the drug in the form of particles of reduced size and in a crystalline form. Gelucire® 44/14 apparently increases the amount of olanzapine dissolved in the solid carrier, but this is presumed to be a metastable state, probably related to the heterogeneous nature of the carrier that delays crystallization of the drug. The high hydrophilicity of the carriers proves suitable to an accelerated and quick release of the drug regardless of aging. Differences in the release profiles between Lutrol- and Gelucire-containing systems were interpreted in terms of the formation of polymer micelles by the Lutrols when in aqueous solution. [ABSTRACT FROM AUTHOR]
Copyright of Pharmaceutics is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:19994923
DOI:10.3390/pharmaceutics5040570